Co-Founder Salary at Anagram BETA

COMPANY OVERVIEW AIRNA is a biotechnology company with a mission to be the leading RNA editing company delivering precision therapies to patients with rare and common diseases. AIRNA is harnessing advances in genetics to develop transformative RNA-editing medicines that improve human health. Our proprietary platform is based on groundbreaking research by pioneers of the field and company co-founders Thorsten Stafforst (University of Tübingen) and Jin Billy Li (Stanford University) and enables optimal potency, safety, and delivery. AIRNA is advancing a robust pipeline of therapeutic candidates that are designed to provide functional cures for severe or chronic diseases by repairing harmful genetic variants or introducing beneficial variants promote optimal health. AIRNA has raised $245 million in financing from a world-class syndicate of investors including Arch Venture Partners, Forbion, Venrock Healthcare Capital Partners, RTW Investments, Nextech Invest, and ND Capital. We value team

Who are we? Gopinion is a small Boston based start up with the goal of bridging the communication gap between businesses and their customers. Through the Gopinion mobile app, users fill out micro-surveys (max 20 seconds), and select an instant reward from either the business they reviewed or any other business in our system. The data from these micro-surveys is collected on the individual business owner's web dashboard where they can engage with the users through our app. What stage are we? We are currently in Alpha testing. We have an app in the app store, and are currently testing a proof-of-concept in 15 locations around the Copley and Harvard Square areas. We have businesses such as Flour Bakery, Burger King, Dependable Cleaners, and the Duck Tours among others. We are in the final stages of a beta version of our product which is set to release in late September, with the Harvard University Dining Services (15 locations in Harvard Square) ready to start with us when we release our

Who we are Zus is a shared health data platform designed to accelerate healthcare data interoperability by providing easy-to-use patient data via API, embedded components, and direct EHR integrations. Founded in 2021 by Jonathan Bush, co-founder and former CEO of athenahealth, Zus partners with HIEs and other data networks to aggregate patient clinical history and then translates that history into user-friendly information at the point of care. Zus's mission is to catalyze healthcare's greatest inventors by maximizing the value of patient insights - so that they can build up, not around. What we're looking for Zus Health is seeking a Director, Forecasting and Business Insights to join our growing team. Reporting directly to the CFO, this role will serve as a key leader for the organization, driving a data-driven approach to business analytics, strategic planning, budgeting, and scenario forecasting across all departments, including Engineering, Product, Commercial, and G&A. This is a h

COMPANY OVERVIEW AIRNA is a biotechnology company with a mission to transform lives, one RNA edit at a time. AIRNA is pioneering the discovery and development of RNA editing therapeutics to realize the therapeutic potential of base editing for patients with rare and common diseases. RNA editing modality is poised to lead the next generation of RNA therapeutics by bringing the precision of gene editing technology with a potent and safe medicine that can be conveniently re-dosed and manufactured. Our RESTORE+™ platform is based on groundbreaking research by academic co-founders Thorsten Stafforst (University of Tübingen) and Jin Billy Li (Stanford University), who were the first to elucidate a therapeutic approach for precise editing of RNA. AIRNA has received $90 million in Series A financing from world class venture capital firms, including Forbion and Arch Venture Partners, and is headquartered in Cambridge, MA with research operations in Tübingen, Germany. JOB DESCRIPTION AIRNA has a

Founder & CEO - Oncology Biotech (ADC/Cancer Stem Cell Therapy) Location: U.S. or Europe | Type: Co-founder Opportunity A preclinical biotech venture is seeking a Founder & CEO to lead development of a first-in-class protein drug conjugate (PDC) targeting cancer stem cells (CSCs)-a critical driver of metastasis, recurrence, and drug resistance. The technology, based on natural ligands of LGR4/5/6 receptors, has shown strong anti-tumor activity in preclinical models of colorectal, ovarian, and gastric cancer. Backed by a prominent research foundation and supported by an experienced inventor, the company is poised for IND-enabling studies and first-in-human trials. Responsibilities: Drive both dilutive and non-dilutive fundraising Shape clinical and regulatory strategy Oversee preclinical and IND-enabling activities Build partnerships with CROs, CDMOs, pharma, and KOLs Lead the company through early clinical development Ideal Profile: Proven experience in biotech fundraising and leadersh

Description Crumbl Cookies is hiring immediately for Closing Shift Leads to join their team! Shift leads work closely with store management to carefully manage one of our working shifts. Duties primarily revolve around the general management of your direct reports, which include, but are not limited to: providing and demonstrating task instructions, keeping attendance, and measuring key performance indicators. You will be expected to keep records and produce reports that will be used to review team performance. In order to be successful in this role, you will need to have excellent communication skills and a passion for excellence, and ensure the bakery is meeting the high standards customers and employees deserve. Previous leadership experience is a plus. Shift lead responsibilities (include but are not limited to): •Manage all the basics of running the store •Make sure employees that report to you meet performance expectations •Keep employees moving at a quick/accurate pace •Handle a

Are you a highly motivated sales professional with a passion for closing new business in an industry ripe for disruption? Do you excel at building long-term relationships with C-suite executives and driving sales cycles from prospecting to closure? Are you ready to be part of a team that is transforming the investment management industry with innovative cloud solutions? If so, we invite you to be a part of our growing sales team. As a Senior Sales Executive at Ridgeline, you will drive net-new customer acquisition and build meaningful client relationships by showcasing Ridgeline's modern platform as a transformational solution. This role offers an exciting opportunity to join our dynamic Go-To-Market team, where you will leverage your expertise in selling complex software solutions to guide prospects through a consultative buying journey. You'll play a key role in expanding Ridgeline's presence while delivering value to our customers through innovative, unified technology. This is an i

COMPANY OVERVIEW AIRNA is a biotechnology company with a mission to transform lives, one RNA edit at a time. AIRNA is pioneering the discovery and development of RNA editing therapeutics to realize the therapeutic potential of base editing for patients with rare and common diseases. RNA editing modality is poised to lead the next generation of RNA therapeutics by bringing the precision of gene editing technology with a potent and safe medicine that can be conveniently re-dosed and manufactured. Our RESTORE+™ platform is based on groundbreaking research by academic co-founders Thorsten Stafforst (University of Tübingen) and Jin Billy Li (Stanford University), who were the first to elucidate a therapeutic approach for precise editing of RNA. AIRNA has received $90 million in Series A financing from world class venture capital firms, including Forbion and Arch Venture Partners, and is headquartered in Cambridge, MA with research operations in Tübingen, Germany. JOB DESCRIPTION The Head of